| Literature DB >> 27557349 |
G Savulich1,2, T Piercy1, A B Brühl1,2,3, C Fox4, J Suckling1,2, J B Rowe2,5,6, J T O'Brien1, B J Sahakian1,2.
Abstract
Cognitive enhancement can benefit the individual and society, but also has associated risks and ethical concerns. Cognitive-enhancing drugs are used in the treatment of neuropsychiatric disorders. Nonpharmacological strategies are also emerging, which have the potential to improve motivational deficits associated with neuropsychiatric symptoms and should be prioritized for development. The increasing lifestyle use of "smart" and other drugs indicates the desire for healthy people to improve themselves. Safety and ethical implications are discussed.Entities:
Mesh：
Substances：
Year: 2016 PMID： 27557349 DOI： 10.1002/cpt.457
Source DB: PubMed Journal: Clin Pharmacol Ther ISSN： 0009-9236 Impact factor: 6.875